Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in mice
Top Cited Papers
- 31 January 2010
- journal article
- Published by Elsevier BV in Food and Chemical Toxicology
- Vol. 48 (1), 409-416
- https://doi.org/10.1016/j.fct.2009.10.030
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Epigallocatechin gallate attenuates experimental non‐alcoholic steatohepatitis induced by high fat dietJournal of Gastroenterology and Hepatology, 2008
- Green Tea Extract Protects Leptin-Deficient, Spontaneously Obese Mice from Hepatic Steatosis and Injury1,Journal of Nutrition, 2008
- Tea and cancer prevention: Molecular mechanisms and human relevanceToxicology and Applied Pharmacology, 2007
- A case of hepatotoxicity caused by green teaFree Radical Biology & Medicine, 2007
- Role of IL-6 in an IL-10 and IL-4 Double Knockout Mouse Model Uniquely Susceptible to Acetaminophen-Induced Liver InjuryChemical Research in Toxicology, 2007
- Effects of Repeated Green Tea Catechin Administration on Human Cytochrome P450 ActivityCancer Epidemiology, Biomarkers & Prevention, 2006
- Green Tea Consumption and Mortality Due to Cardiovascular Disease, Cancer, and All Causes in JapanJAMA, 2006
- Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: Dermal, acute and short-term toxicity studiesFood and Chemical Toxicology, 2006
- Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applicationsLife Sciences, 2006
- Targeting Multiple Signaling Pathways by Green Tea Polyphenol (−)-Epigallocatechin-3-GallateCancer Research, 2006